Suchergebnisse - (Person:"Lu, Qiong")

PubPharm (6)

1

Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants

enthalten in: Journal of medical virology | 2024

von Liang, Z. | Tong, J. | Sun, Z. | +11

2

Development of an automated, high-throughput SARS-CoV-2 neutralization assay based on a pseudotyped virus using a vesicular stomatitis virus (VSV) vector

enthalten in: Emerging microbes & infections | 2023

von Liang, Z. | Wu, X. | Wu, J. | +11

3

Analysis of SARS-CoV-2 variants B.1.617 : host tropism, proteolytic activation, cell-cell fusion, and neutralization sensitivity

enthalten in: Emerging microbes & infections | 2022

von Zhang, L. | Li, Q. | Wu, J. | +19

4

SARS-CoV-2 501Y.V2 variants lack higher infectivity but do have immune escape

enthalten in: Cell | 2021

von Li, Q. | Nie, J. | Wu, J. | +24

CommentIn: Signal Transduct Target Ther. 2021 Jul 27;6(1):284. - PMID 34315847

5

Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2

enthalten in: Emerging microbes & infections | 2020

von Nie, J. | Li, Q. | Wu, J. | +15

6

Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay

enthalten in: Nature protocols | 2020

von Nie, J. | Li, Q. | Wu, J. | +15

CommentIn: Signal Transduct Target Ther. 2021 Dec 13;6(1):419. - PMID 34903732

1
[1]